Influenza
Showing NaN - NaN of 91
Influenza Trial in Worldwide (Influenza vaccine GSK2321138A, FluarixTM, Influenza vaccine GSK2604409A)
Completed
- Influenza
- Influenza vaccine GSK2321138A
- +2 more
-
Sacramento, California
- +58 more
Aug 22, 2018
Influenza Trial in Houston (Monovalent influenza A/H7N9 virus vaccine)
Completed
- Influenza
- Monovalent influenza A/H7N9 virus vaccine
-
Houston, TexasBaylor College of Medicine - Molecular Virology and Microbiology
Aug 20, 2018
Influenza Trial in Spain, United States (GSK Biologicals' influenza vaccine GSK2186877A, GSK Biologicals' Fluarix)
Completed
- Influenza
- GSK Biologicals' influenza vaccine GSK2186877A
- GSK Biologicals' Fluarix
-
Houston, Texas
- +3 more
Jul 2, 2018
Influenza Trial in Worldwide (Trivalent influenza vaccine (TIVc), Trivalent influenza vaccine-licensed)
Completed
- Influenza
- Trivalent influenza vaccine (TIVc)
- Trivalent influenza vaccine-licensed
-
Phoenix, Arizona
- +26 more
Jun 11, 2018
Influenza Trial in Worldwide (GSK Bio's influenza vaccine GSK2186877A, Fluarix TM)
Completed
- Influenza
- GSK Bio's influenza vaccine GSK2186877A
- Fluarix TM
-
Alabaster, Alabama
- +273 more
May 8, 2018
Influenza Trial in United States (CSL's 2009 H1N1 Influenza Vaccine (CSL425), Placebo)
Completed
- Influenza
- CSL's 2009 H1N1 Influenza Vaccine (CSL425)
- Placebo
-
Chandler, Arizona
- +12 more
Apr 25, 2018
Influenza Trial in United States (Influenza Virus Vaccine, Monovalent A/H3N2v A/Minnesota/11/2010 NYMC X-203)
Completed
- Influenza
- Influenza Virus Vaccine, Monovalent A/H3N2v A/Minnesota/11/2010 NYMC X-203
-
Atlanta, Georgia
- +7 more
Jul 3, 2017
Vaccine Preventable Diseases, Meningococcal Disease, Human Papillomavirus Trial in United States (Point-of-Care Prompt)
Completed
- Vaccine Preventable Diseases
- +4 more
- Point-of-Care Prompt
-
Little Rock, Arkansas
- +21 more
Apr 28, 2017
Influenza Trial in United States (Influenza)
Completed
- Influenza
- Influenza
-
Clearwater, Florida
- +14 more
Jan 16, 2017
Influenza Trial in United States (Influenza Virus Vaccine, Monovalent A/H5N1 A/Indonesia/05/2005)
Completed
- Influenza
- Influenza Virus Vaccine, Monovalent A/H5N1 A/Indonesia/05/2005
-
Stanford, California
- +7 more
Dec 22, 2016
Influenza Trial in United States (20 mg laninamivir octanoate, Placebo, 40 mg laninamivir octanoate)
Terminated
- Influenza
- 20 mg laninamivir octanoate
- +2 more
-
Phoenix, Arizona
- +27 more
Mar 22, 2016
Novel Influenza A (H1N1) Surveillance Registry
Completed
- Novel Influenza A
- +2 more
-
Anchorage, Alaska
- +85 more
Apr 13, 2016
Influenza Trial in United States (DNA vaccine, TIV)
Completed
- Influenza
- DNA vaccine
- TIV
-
Decatur, Georgia
- +3 more
Mar 23, 2016